Details for: CGB5

Gene ID: 93659

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: CGB5

Ensembl ID: ENSG00000189052

Description: chorionic gonadotropin subunit beta 5

Cell Significance Landscape

Associated with

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • syncytiotrophoblast cell CL0000525
    CSI 3.87
    rCSI 11.14%
    PRS 99.83

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.
Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [CGB5](/details-gene/93659) (Chorionic Gonadotropin Subunit Beta 5) is a protein-coding gene located on chromosome 19q13.33. It encodes a beta subunit of human chorionic gonadotropin (hCG), a glycoprotein hormone crucial for establishing and maintaining pregnancy. Functionally, [CGB5](/details-gene/93659) is involved in peptide hormone biosynthesis and metabolism. Expression data indicates that this gene is an exceptionally specific marker, with its activity almost exclusively confined to the [syncytiotrophoblast cell](/details-cell/CL0000525) of the placenta. ## Cellular Roles and Expression Landscape The expression profile of [CGB5](/details-gene/93659) demonstrates a remarkable degree of cellular specificity. **Overall**, the gene shows its highest significance and is a defining marker for the [syncytiotrophoblast cell](/details-cell/CL0000525) (CSI: 3.87). This cell type forms the outer epithelial layer of the placental villi and is the primary site of nutrient exchange and hormone production during pregnancy. The highly restricted expression pattern suggests that [CGB5](/details-gene/93659) serves a specialized function integral to the identity and endocrine activity of this specific placental cell lineage. Its absence from other cell types underscores its role as a highly specific biomarker for syncytiotrophoblasts. ## Pathways and Molecular Function The functional annotations for [CGB5](/details-gene/93659) are consistent with its role as a component of a secreted hormone. It is a key participant in pathways such as '[Glycoprotein hormones](/details-pathway/R-HSA-209822)', '[Peptide hormone biosynthesis](/details-pathway/R-HSA-209952)', and '[Peptide hormone metabolism](/details-pathway/R-HSA-2980736)'. These pathways describe the synthesis and processing of hCG, which is essential for maintaining the corpus luteum and progesterone production in early pregnancy. Additionally, [CGB5](/details-gene/93659) is associated with transcriptional regulation pathways, including '[Gene expression (transcription)](/details-pathway/R-HSA-74160)' and '[Transcriptional regulation by the ap-2 (tfap2) family of transcription factors](/details-pathway/R-HSA-8864260)'. This suggests that the highly cell-type-specific expression of [CGB5](/details-gene/93659) is tightly controlled at the transcriptional level, likely by lineage-specific factors like the TFAP2 family, which are known to be important in placental development. ## Research Directions While [CGB5](/details-gene/93659) is central to pregnancy, its ectopic expression is a well-known biomarker for several malignancies, including choriocarcinomas and germ cell tumors. This dual role presents significant research opportunities. ### Proposed Hypotheses 1. The highly restricted expression of [CGB5](/details-gene/93659) in [syncytiotrophoblast cells](/details-cell/CL0000525) is controlled by a unique epigenetic landscape and a specific combinatorial code of transcription factors, such as those from the TFAP2 family, which are deregulated during malignant transformation, leading to its ectopic expression in cancer. 2. Ectopic production of the hCG hormone, containing the [CGB5](/details-gene/93659) subunit, by tumor cells actively promotes cancer progression by mimicking pregnancy-related immune evasion mechanisms, thereby protecting the tumor from immune surveillance. ### Key Experiments To test the hypothesis that ectopic [CGB5](/details-gene/93659) expression promotes immune evasion, one could co-culture cancer cell lines engineered to express and secrete hCG (e.g., lung adenocarcinoma or melanoma) with primary human immune cells, such as T cells and NK cells. The functional consequences, including T cell activation (e.g., CD69 expression), cytokine production (e.g., IFN-gamma), and NK cell-mediated cytotoxicity, would be measured. A reduction in anti-tumor immune responses in the presence of hCG would support the hypothesis that it contributes to an immunosuppressive tumor microenvironment. ### Therapeutic Potential As a secreted protein with extremely limited expression in healthy, non-pregnant individuals, [CGB5](/details-gene/93659) (as part of the hCG hormone) represents an excellent therapeutic target for cancers that express it ectopically. Its high tumor specificity minimizes the risk of on-target, off-tumor toxicity. Therapeutic strategies would focus on **inhibition** or targeting. This could include the development of antibody-drug conjugates (ADCs) that deliver a cytotoxic payload specifically to hCG-producing tumor cells, or therapeutic vaccines designed to elicit an immune response against the hCG hormone, thereby neutralizing its immunosuppressive effects and enabling the host immune system to attack the tumor.